Page last updated: 2024-11-05

tyramine and Multiple Sclerosis

tyramine has been researched along with Multiple Sclerosis in 2 studies

Multiple Sclerosis: An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)

Research Excerpts

ExcerptRelevanceReference
"Dissociating glucocorticoid receptor (GR) ligands hold great promise for treating inflammatory disorders since it is assumed that they exert beneficial activities mediated by transrepression but avoid adverse effects of GR action requiring transactivation."1.35Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis. ( Hanisch, UK; John, M; Lühder, F; Menzfeld, C; Reichardt, HM; Tischner, D; Tuckermann, JP; van den Brandt, J; Wüst, S, 2009)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
van Loo, G1
Sze, M1
Bougarne, N1
Praet, J1
Mc Guire, C1
Ullrich, A1
Haegeman, G1
Prinz, M1
Beyaert, R1
De Bosscher, K1
Wüst, S1
Tischner, D1
John, M1
Tuckermann, JP1
Menzfeld, C1
Hanisch, UK1
van den Brandt, J1
Lühder, F1
Reichardt, HM1

Other Studies

2 other studies available for tyramine and Multiple Sclerosis

ArticleYear
Antiinflammatory properties of a plant-derived nonsteroidal, dissociated glucocorticoid receptor modulator in experimental autoimmune encephalomyelitis.
    Molecular endocrinology (Baltimore, Md.), 2010, Volume: 24, Issue:2

    Topics: Acetates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Astrocytes; Cells, Cultured; Cytokines;

2010
Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis.
    PloS one, 2009, Dec-07, Volume: 4, Issue:12

    Topics: Acetates; Animals; Apoptosis; Aziridines; Cell Adhesion Molecules; Disease Models, Animal; Dose-Resp

2009